Times are listed in pacific time, separate theme for each day.
Each talk is a 20-minute presentation, including a brief Q&A / Expert panel discussion sessions (2-4 people)
Breakout discussions will encourage interactions among participants
Recordings 2025
Session Recordings
Innate immunity and hostdirected therapies; Tom HawnAdaptive immunity to M.tuberculosis; Chetan SeshadriGranulomas and in vivo model of TB pathogenesis: dissecting mechanisms of protection and dissemination; Kevin UrdahlTB controlled human infection model (TB-CHIM); Rhea ColerTB vaccine trials; Andrew Fiore-GartlandSession 1 Panel Discussion
Pathogenesis and drug targets; David ShermanSystems biology approaches to drug discovery; Nitin BaligaDrug discovery and development; Arielle ButtsTreatment regimens, including PLHIV; Adrienne ShapiroTreatment for drug-resistant and extrapulmonary; Bijan GhassemiehSession 2 Panel Discussion
TB biomarkers and diagnostics; Paul DrainNovel biomarkers for incipient/subclinical TB; Javeed ShahTongue swabs and other nonsputum based diagnostics; Jerry CangelosiOrganizing, Funding, and Media for TB advocacy; Erin McConnell, TAGSession 3 Panel Discussion
Aerosol biology and TB transmission; David HorneResister populations and Mtb transmission; Jason SimmonsImaging and other clinical measures for risk of Mtb transmission; Engi AttiaTB preventive treatment and novel regimens; Jennifer RossTB in Pregnancy; Sylvia LaCourseSession 4 Panel Discussion
TB modeling and phylogenetics; Josh HerbeckUsing mobile health technologies for TB; Sarah IribarrenPediatrics and special populations; Rafael HernandezDiagnostics for pregnant women and PLHIV; Grace John-Stewart